Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis

Kathleen E. Simpson, Madeleine W. Cunningham, Caroline K. Lee, Kent Ward, Alan Tong, Saar Danon, Catherine Simon, Jeffrey W Delaney, Charles E. Canter

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background Host autoimmune activity in myocarditis has been proposed to play a role in development of cardiac disease, but evidence of autoimmunity and relationship to outcomes have not been evaluated in pediatric myocarditis. Methods We performed a multi-institutional study of children with clinical myocarditis. Newly diagnosed patients were followed for up to 12 months and previously diagnosed patients at a single follow-up for serum levels of autoantibodies to human cardiac myosin, beta-adrenergic receptors 1 and 2, muscarinic-2 receptors, and antibody-mediated protein kinase A (PKA) activation in heart cells in culture. Results were compared with those of healthy control children. Results Both previously diagnosed patient at follow-up (P = .0061) and newly diagnosed patients at presentation (P = .0127) had elevated cardiac myosin antibodies compared with control subjects. Antibody levels were not associated with recovery status at follow-up in either group. PKA activation was higher at presentation in the newly diagnosed patients who did not recovery normal function (P = .042). Conclusions Children with myocarditis have evidence of autoantibodies against human cardiac myosin at diagnosis and follow-up compared with control subjects. Differences in antibody-mediated cell signaling may contribute to differences in patient outcomes, as suggested by elevated antibody-mediated PKA activation in heart cells by the serum from nonrecovered patients.

Original languageEnglish (US)
Pages (from-to)520-528
Number of pages9
JournalJournal of Cardiac Failure
Volume22
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Cardiac Myosins
Myocarditis
Autoimmunity
Cyclic AMP-Dependent Protein Kinases
Antibodies
Autoantibodies
Adrenergic beta-1 Receptors
Adrenergic beta-2 Receptors
Ventricular Myosins
Recovery of Function
Muscarinic Receptors
Serum
Heart Diseases
Cell Culture Techniques
Pediatrics

Keywords

  • Myocarditis
  • autoantibody
  • autoimmunity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Simpson, K. E., Cunningham, M. W., Lee, C. K., Ward, K., Tong, A., Danon, S., ... Canter, C. E. (2016). Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. Journal of Cardiac Failure, 22(7), 520-528. https://doi.org/10.1016/j.cardfail.2016.02.009

Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. / Simpson, Kathleen E.; Cunningham, Madeleine W.; Lee, Caroline K.; Ward, Kent; Tong, Alan; Danon, Saar; Simon, Catherine; Delaney, Jeffrey W; Canter, Charles E.

In: Journal of Cardiac Failure, Vol. 22, No. 7, 01.07.2016, p. 520-528.

Research output: Contribution to journalArticle

Simpson, KE, Cunningham, MW, Lee, CK, Ward, K, Tong, A, Danon, S, Simon, C, Delaney, JW & Canter, CE 2016, 'Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis', Journal of Cardiac Failure, vol. 22, no. 7, pp. 520-528. https://doi.org/10.1016/j.cardfail.2016.02.009
Simpson, Kathleen E. ; Cunningham, Madeleine W. ; Lee, Caroline K. ; Ward, Kent ; Tong, Alan ; Danon, Saar ; Simon, Catherine ; Delaney, Jeffrey W ; Canter, Charles E. / Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. In: Journal of Cardiac Failure. 2016 ; Vol. 22, No. 7. pp. 520-528.
@article{0320c62fa035419990e1348ea0110503,
title = "Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis",
abstract = "Background Host autoimmune activity in myocarditis has been proposed to play a role in development of cardiac disease, but evidence of autoimmunity and relationship to outcomes have not been evaluated in pediatric myocarditis. Methods We performed a multi-institutional study of children with clinical myocarditis. Newly diagnosed patients were followed for up to 12 months and previously diagnosed patients at a single follow-up for serum levels of autoantibodies to human cardiac myosin, beta-adrenergic receptors 1 and 2, muscarinic-2 receptors, and antibody-mediated protein kinase A (PKA) activation in heart cells in culture. Results were compared with those of healthy control children. Results Both previously diagnosed patient at follow-up (P = .0061) and newly diagnosed patients at presentation (P = .0127) had elevated cardiac myosin antibodies compared with control subjects. Antibody levels were not associated with recovery status at follow-up in either group. PKA activation was higher at presentation in the newly diagnosed patients who did not recovery normal function (P = .042). Conclusions Children with myocarditis have evidence of autoantibodies against human cardiac myosin at diagnosis and follow-up compared with control subjects. Differences in antibody-mediated cell signaling may contribute to differences in patient outcomes, as suggested by elevated antibody-mediated PKA activation in heart cells by the serum from nonrecovered patients.",
keywords = "Myocarditis, autoantibody, autoimmunity",
author = "Simpson, {Kathleen E.} and Cunningham, {Madeleine W.} and Lee, {Caroline K.} and Kent Ward and Alan Tong and Saar Danon and Catherine Simon and Delaney, {Jeffrey W} and Canter, {Charles E.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.cardfail.2016.02.009",
language = "English (US)",
volume = "22",
pages = "520--528",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "7",

}

TY - JOUR

T1 - Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis

AU - Simpson, Kathleen E.

AU - Cunningham, Madeleine W.

AU - Lee, Caroline K.

AU - Ward, Kent

AU - Tong, Alan

AU - Danon, Saar

AU - Simon, Catherine

AU - Delaney, Jeffrey W

AU - Canter, Charles E.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Background Host autoimmune activity in myocarditis has been proposed to play a role in development of cardiac disease, but evidence of autoimmunity and relationship to outcomes have not been evaluated in pediatric myocarditis. Methods We performed a multi-institutional study of children with clinical myocarditis. Newly diagnosed patients were followed for up to 12 months and previously diagnosed patients at a single follow-up for serum levels of autoantibodies to human cardiac myosin, beta-adrenergic receptors 1 and 2, muscarinic-2 receptors, and antibody-mediated protein kinase A (PKA) activation in heart cells in culture. Results were compared with those of healthy control children. Results Both previously diagnosed patient at follow-up (P = .0061) and newly diagnosed patients at presentation (P = .0127) had elevated cardiac myosin antibodies compared with control subjects. Antibody levels were not associated with recovery status at follow-up in either group. PKA activation was higher at presentation in the newly diagnosed patients who did not recovery normal function (P = .042). Conclusions Children with myocarditis have evidence of autoantibodies against human cardiac myosin at diagnosis and follow-up compared with control subjects. Differences in antibody-mediated cell signaling may contribute to differences in patient outcomes, as suggested by elevated antibody-mediated PKA activation in heart cells by the serum from nonrecovered patients.

AB - Background Host autoimmune activity in myocarditis has been proposed to play a role in development of cardiac disease, but evidence of autoimmunity and relationship to outcomes have not been evaluated in pediatric myocarditis. Methods We performed a multi-institutional study of children with clinical myocarditis. Newly diagnosed patients were followed for up to 12 months and previously diagnosed patients at a single follow-up for serum levels of autoantibodies to human cardiac myosin, beta-adrenergic receptors 1 and 2, muscarinic-2 receptors, and antibody-mediated protein kinase A (PKA) activation in heart cells in culture. Results were compared with those of healthy control children. Results Both previously diagnosed patient at follow-up (P = .0061) and newly diagnosed patients at presentation (P = .0127) had elevated cardiac myosin antibodies compared with control subjects. Antibody levels were not associated with recovery status at follow-up in either group. PKA activation was higher at presentation in the newly diagnosed patients who did not recovery normal function (P = .042). Conclusions Children with myocarditis have evidence of autoantibodies against human cardiac myosin at diagnosis and follow-up compared with control subjects. Differences in antibody-mediated cell signaling may contribute to differences in patient outcomes, as suggested by elevated antibody-mediated PKA activation in heart cells by the serum from nonrecovered patients.

KW - Myocarditis

KW - autoantibody

KW - autoimmunity

UR - http://www.scopus.com/inward/record.url?scp=84962094527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962094527&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2016.02.009

DO - 10.1016/j.cardfail.2016.02.009

M3 - Article

C2 - 26941007

AN - SCOPUS:84962094527

VL - 22

SP - 520

EP - 528

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 7

ER -